CVR number 40805125
Industry 721000

Jacobsen Scientific ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 26.1% 12.1% 35.3% 27.9%  
Credit score (0-100)  0 3 18 0 1  
Credit rating  N/A B BB C B  
Credit limit (kDKK)  0.0 -0.0 0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Gross profit  0.0 -113 21.5 -158 -145  
EBITDA  0.0 -113 21.5 -249 -291  
EBIT  0.0 -113 21.5 -249 -291  
Pre-tax profit (PTP)  0.0 -114.4 20.2 73.6 18.4  
Net earnings  0.0 -82.9 16.9 49.3 18.7  
Pre-tax profit without non-rec. items  0.0 -114 20.2 73.6 18.4  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 -42.9 -26.0 23.3 42.0  
Interest-bearing liabilities  0.0 114 139 7.5 0.1  
Balance sheet total (assets)  0.0 71.1 112 128 84.3  
Net Debt  0.0 74.4 54.5 -116 -79.1  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -113 21.5 -158 -145  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 8.1%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 -91.0 -146.0  
Balance sheet total (assets)  0 71 112 128 84  
Balance sheet change%  0.0% 0.0% 58.0% 14.1% -34.3%  
Added value  0.0 -112.9 21.5 -158.0 -145.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 1.0 -1.0 -2.0  

Profitability 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 157.6% 200.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -99.0% 17.0% 56.8% 18.3%  
ROI %  0.0% -99.0% 17.0% 60.6% 21.8%  
ROE %  0.0% -116.6% 18.4% 72.7% 57.3%  

Solidity 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  0.0% -37.6% -18.8% 18.2% 49.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -65.9% 254.2% 46.6% 27.1%  
Gearing %  0.0% -265.8% -533.2% 32.3% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 2.6% 1.0% 3.0% 26.4%  

Liquidity 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.0 0.5 0.8 17.0 1,499.4  
Current Ratio  0.0 0.5 0.8 17.0 1,499.4  
Cash and cash equivalent  0.0 39.6 84.2 123.7 79.1  

Capital use efficiency 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -53.3 -33.1 120.7 83.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0